Hosted on MSN1mon
Amgen says no concerns around weight loss drug’s bone density data after stock fallsAnalysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks. Amgen on Wednesday said there is no link between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback